UY29625A1 - Uso de moduladores no esteroides de receptores de progesterona - Google Patents

Uso de moduladores no esteroides de receptores de progesterona

Info

Publication number
UY29625A1
UY29625A1 UY29625A UY29625A UY29625A1 UY 29625 A1 UY29625 A1 UY 29625A1 UY 29625 A UY29625 A UY 29625A UY 29625 A UY29625 A UY 29625A UY 29625 A1 UY29625 A1 UY 29625A1
Authority
UY
Uruguay
Prior art keywords
therapy
prevention
well
progesterone receptors
diseases
Prior art date
Application number
UY29625A
Other languages
English (en)
Inventor
Ulrike Fuhrmann
Wolfgang Schwede
Norbert Schmees
Carsten Moller
Anja Schmidt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of UY29625A1 publication Critical patent/UY29625A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La presente invención se refiere a modulares no esteroides de receptores de progesterona de la fórmula general I, a su uso para preparar medicamentos, así como a las composiciones farmacéuticas que contienen estos compuestos. Los compuestos según la invención son apropiados para la terapia y la prevención de enfermedades ginecológicas tales como endometriosos, leiomiomas del útero, hemorragias disfuncionales y dismenorrea, así como para la terapia y la prevención de tumores dependientes de hormonas y para usar en el control de la fertilidad femenina y la terapia de reemplazo hormonal.
UY29625A 2005-06-24 2006-06-26 Uso de moduladores no esteroides de receptores de progesterona UY29625A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030293A DE102005030293A1 (de) 2005-06-24 2005-06-24 Verwendung von nichtsteroidale Progesteronrezeptor-Modulatoren

Publications (1)

Publication Number Publication Date
UY29625A1 true UY29625A1 (es) 2007-01-31

Family

ID=37421093

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29625A UY29625A1 (es) 2005-06-24 2006-06-26 Uso de moduladores no esteroides de receptores de progesterona

Country Status (12)

Country Link
US (1) US20060293317A1 (es)
EP (1) EP1895999A1 (es)
JP (1) JP2008543906A (es)
AR (1) AR054803A1 (es)
CA (1) CA2612161A1 (es)
DE (1) DE102005030293A1 (es)
DO (1) DOP2006000147A (es)
GT (1) GT200600270A (es)
PE (1) PE20070324A1 (es)
TW (1) TW200726461A (es)
UY (1) UY29625A1 (es)
WO (1) WO2007022824A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
US20090099147A1 (en) * 2007-07-10 2009-04-16 Schwede Wolfgnag Non-steroidal progesterone receptor modulators
DE102007058747A1 (de) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
EP2070909A1 (de) * 2007-12-15 2009-06-17 Bayer Schering Pharma AG Nichtsteroidale Progesteronrezeptor-Modulatoren

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245804B1 (en) * 1997-05-30 2001-06-12 Schering Aktiengesellschaft Nonsteroidal gestagens
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
DE60309829T2 (de) * 2002-01-14 2007-09-13 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Glucocorticoidmimetika, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische formulierungen und ihre verwendungen
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
EA200600148A1 (ru) * 2003-07-01 2006-08-25 Шеринг Акциенгезельшафт Гетероциклически замещённые производные пентанола, способ их получения и их применение в качестве ингибиторов воспаления
US20050090559A1 (en) * 2003-07-01 2005-04-28 Markus Berger Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents

Also Published As

Publication number Publication date
DE102005030293A1 (de) 2007-01-04
GT200600270A (es) 2008-05-05
DOP2006000147A (es) 2006-12-31
CA2612161A1 (en) 2007-03-01
JP2008543906A (ja) 2008-12-04
AR054803A1 (es) 2007-07-18
WO2007022824A1 (en) 2007-03-01
US20060293317A1 (en) 2006-12-28
EP1895999A1 (en) 2008-03-12
PE20070324A1 (es) 2007-04-12
TW200726461A (en) 2007-07-16

Similar Documents

Publication Publication Date Title
UY33470A (es) Derivados de 6,7-dihidro-5h-benzo[7]anulenos, métodos para su preparación, preparaciones farmacéuticas que los contienen y su uso para la preparación de medicamentos
SV2010003580A (es) Agonistas novedosos de los receptores de glucocorticoides
CR10875A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides
AR051904A1 (es) Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r)
CR10489A (es) Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides
UY29626A1 (es) Moduladores no esteroides de receptores de progesterona
CU20140064A7 (es) Derivados de 6,7- dihidro-5h-benzo[7]anuleno, procesos para su preparación, productos farmacéuticos que comprenden a los mismos y su uso en la preparación de medicamentos
UY29625A1 (es) Uso de moduladores no esteroides de receptores de progesterona
CR20190379A (es) Moduladores del receptor de estrógeno
ECSP078044A (es) Moduladores no esteroides de receptor de progesterona
CR9627A (es) Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
UY31326A (es) Compuestos de quinolina apropiados para tratar trastornos que responden a la modulación del receptor de serotonina 5-ht6
UY30805A1 (es) Moduladores no esteroides de receptores de progesterona
UY30815A1 (es) Moduladores no esteroidales del receptor de progesterona
CL2008002027A1 (es) Compuestos derivados de 16alfa-fluoro-estra-1,3,5(10)-trieno obeta-sustituido;composicion farmaceutica; y uso de los compuestos para tratar enfermedades inducidas por la deficiencia de estrogeno, infertilidad, sintomas peri y posmenopausicos, artritis reumatica, enfermedades intestinales inflamatorias, entre otras.
TH85615A (th) สารปรับโพรเจสเตอโรนรีเซปเตอร์ชนิดนอนสเตียรอยด์
CU20090109A7 (es) Derivados de éster y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160831